Genertec Universal Medical Group Company Limited (HKG:2666)

HKG:2666 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,475	2,108	2,379	2,849	2,705	2,342
Long-Term Investments	127.58	226.95	275.42	990.05	1,034	986.86
Trading Asset Securities	5.98	-	160.69	309.33	131.61	-
Loans & Lease Receivables	71,498	70,022	71,577	67,262	64,883	60,565
Other Receivables	7.05	577.31	711.52	526.31	517.99	248.86
Property, Plant & Equipment	7,877	7,777	7,627	5,553	4,975	3,318
Goodwill	382.54	384.3	381	286.54	102.25	102.25
Other Intangible Assets	274.93	284.11	303.79	161.27	79.17	46.18
Other Current Assets	2,306	872	814.76	849.54	938.97	1,090
Long-Term Deferred Tax Assets	951.63	872.13	773.88	702.16	742.55	561.18
Other Long-Term Assets	553.38	262.55	520.95	424.67	482.44	374.14
Total Assets	86,917	84,318	86,032	80,345	76,980	69,900

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2,643	2,905	2,776	2,989	2,294	1,112
Accrued Expenses	-	1,602	1,077	1,221	1,129	1,195
Short-Term Debt	8,751	6,523	5,456	6,601	2,519	3,878
Current Portion of Long-Term Debt	16,258	13,255	16,040	15,879	17,513	10,094
Current Portion of Leases	50.48	52.52	692.66	84.25	807.94	1,120
Long-Term Debt	23,910	28,015	29,271	24,866	26,010	28,855
Long-Term Leases	594.73	491.55	561.84	245.92	181.99	779.75
Long-Term Unearned Revenue	-	108.5	114.23	28.93	21.25	12.09
Current Income Taxes Payable	197.01	131.91	164.37	119.64	84.1	109.61
Other Current Liabilities	4,635	1,345	2,053	2,931	1,851	1,074
Pension & Post-Retirement Benefits	-	91.71	88.35	82.95	84.92	88.51
Other Long-Term Liabilities	4,095	4,315	4,509	4,679	4,499	3,810
Total Liabilities	61,135	59,279	63,163	59,977	57,260	52,277

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5,984	5,984	5,297	5,297	5,297	5,297
Retained Earnings	13,974	13,342	11,789	10,365	9,008	7,705
Comprehensive Income & Other	1,666	1,617	1,767	1,688	1,335	1,763
Total Common Equity	21,624	20,943	18,854	17,350	15,641	14,766
Minority Interest	4,159	4,096	4,016	3,018	4,080	2,857
Shareholders' Equity	25,782	25,039	22,870	20,368	19,721	17,623
Total Liabilities & Equity	86,917	84,318	86,032	80,345	76,980	69,900

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	49,565	48,337	52,022	47,676	47,032	44,727
Net Cash (Debt)	-47,084	-46,230	-49,482	-44,518	-44,195	-42,385
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-23.31	-22.96	-24.62	-21.37	-21.28	-20.80
Filing Date Shares Outstanding	2,014	2,014	1,892	1,892	1,892	1,892
Total Common Shares Outstanding	2,014	2,014	1,892	1,892	1,892	1,892
Working Capital	44,215	48,254	47,533	42,154	43,102	45,780
Book Value Per Share	10.74	10.40	9.97	9.17	8.27	7.81
Tangible Book Value	20,966	20,274	18,169	16,902	15,459	14,617
Tangible Book Value Per Share	10.41	10.07	9.61	8.94	8.17	7.73

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error